SPRINT’s 60-day Treatment May Eliminate Need for Permanent Implant The double-blinded, randomized controlled study was awarded “Best of Meeting” at the 18th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine in New Orleans and has now…
The SPRINT PNS System is designed to provide sustained pain relief without a permanent implant Cleveland, Ohio—December 4, 2019—SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th SPRINT Peripheral…
© 2020 SPR Therapeutics
The SPRINT PNS System is indicated for up to 60 days in the back and/or extremities for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the craniofacial region. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.
View References for support of all claims.
The SPRINT® PNS System, MicroLead™, OnePass Introducer™, Rethink Your Pain Strategy™, Outsmart Pain™, Sustained Pain Relief Starts Here™, Life. Get Back to It.™ and SPR® are registered or common law trademarks of SPR Therapeutics, Inc.